These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8220400)

  • 1. Planning survival studies to compare a treatment to an active control.
    Bristol DR
    J Biopharm Stat; 1993 Sep; 3(2):153-8. PubMed ID: 8220400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of factorial survival experiments.
    Slud EV
    Biometrics; 1994 Mar; 50(1):25-38. PubMed ID: 8086609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A ratio test in active control non-inferiority trials with a time-to-event endpoint.
    Wang YC; Chen G; Chi GY
    J Biopharm Stat; 2006; 16(2):151-64. PubMed ID: 16584064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
    Kim K; Boucher H; Tsiatis AA
    Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selecting factors predictive of heterogeneity in multivariate event time data.
    Dunson DB; Chen Z
    Biometrics; 2004 Jun; 60(2):352-8. PubMed ID: 15180660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A group-sequential design for clinical trials with treatment selection.
    Stallard N; Friede T
    Stat Med; 2008 Dec; 27(29):6209-27. PubMed ID: 18792085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size for two-stage studies with maintenance therapy.
    Feng W; Wahed AS
    Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
    Lachin JM
    Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical analysis of joint short-term and long-term survival in resuscitation research.
    Babbs CF
    Resuscitation; 2007 Nov; 75(2):323-31. PubMed ID: 17583410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring a three-armed clinical trial with survival endpoints: Fisher's least significant difference approach.
    Chen PL; Dominik R
    J Biopharm Stat; 2004 Aug; 14(3):791-801. PubMed ID: 15468765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing differences between nested covariance structure models: Power analysis and null hypotheses.
    MacCallum RC; Browne MW; Cai L
    Psychol Methods; 2006 Mar; 11(1):19-35. PubMed ID: 16594765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test homogeneity of risk difference across subgroups in clinical trials.
    Zhang L; Yang H; Cho I
    J Biopharm Stat; 2009; 19(1):67-76. PubMed ID: 19127467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of methods for futility stopping based on conditional power.
    Lachin JM
    Stat Med; 2005 Sep; 24(18):2747-64. PubMed ID: 16134130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection designs for pilot studies based on survival.
    Liu PY; Dahlberg S; Crowley J
    Biometrics; 1993 Jun; 49(2):391-8. PubMed ID: 8369375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size determination using an interim analysis.
    Bristol DR
    J Biopharm Stat; 1993 Sep; 3(2):159-66. PubMed ID: 8220401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size calculation for the weighted rank statistics with paired survival data.
    Jung SH
    Stat Med; 2008 Jul; 27(17):3350-65. PubMed ID: 18205148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tests of non-null hypothesis on proportions for stratified data.
    Zhao G
    Stat Med; 2008 Apr; 27(9):1429-46. PubMed ID: 17668916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multistage and mixture parallel gatekeeping procedures in clinical trials.
    Dmitrienko A; Kordzakhia G; Tamhane AC
    J Biopharm Stat; 2011 Jul; 21(4):726-47. PubMed ID: 21516566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size and duration for cohort studies of survival time with covariables.
    Taulbee JD; Symons MJ
    Biometrics; 1983 Jun; 39(2):351-60. PubMed ID: 6354287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alternative approach to assess exchangeability of a test treatment and the standard treatment with normally distributed response.
    Tsong Y; Shen M
    J Biopharm Stat; 2007; 17(2):329-38. PubMed ID: 17365227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.